Heart Health Panel

A standard cholesterol test gives you four numbers. Those numbers catch some heart risk, but they miss a surprising amount. You can have normal LDL cholesterol and still carry dangerous levels of the particles that actually lodge in artery walls. You can have textbook lipids while silent inflammation doubles your odds of a heart attack. This panel closes those gaps by combining cholesterol measurements with particle counts, inflammatory signaling, metabolic health, and a liver enzyme that flags the metabolic dysfunction feeding the whole process.

The reason these ten tests belong together is that heart disease is not caused by one thing. It is driven by overlapping forces: too many artery-damaging particles in the blood, chronic low-grade inflammation, insulin resistance that warps your lipid profile from the inside, and liver fat that accelerates all three. Measuring just one dimension leaves you guessing about the others.

What This Panel Reveals

The tests in this panel cover four distinct drivers of cardiovascular disease. Each driver can operate independently, which is why checking only one category can give you a false sense of security.

Atherogenic Particle Burden

The cholesterol measurements (total, LDL, HDL, VLDL, and triglycerides) give you the traditional lipid picture. But cholesterol concentration is only a proxy for what actually matters: the number of particles carrying that cholesterol into your artery walls. Two people with identical LDL cholesterol levels can have very different numbers of LDL particles, and the person with more particles faces higher risk.

That is where apolipoprotein B (ApoB) comes in. Every particle capable of causing atherosclerosis (the buildup of fatty plaques inside artery walls), whether it is an LDL particle, a VLDL remnant, or an intermediate density particle, carries exactly one ApoB molecule on its surface. Your ApoB level is effectively a direct count of all the particles that can damage your arteries. Pooled data from large cohort studies has consistently shown that ApoB is a stronger predictor of cardiovascular events than either LDL cholesterol or non-HDL cholesterol, particularly in people whose LDL appeared normal.

Inherited Particle Risk

Lipoprotein(a), often written as Lp(a), is a genetically determined lipoprotein that standard cholesterol tests do not measure. Your Lp(a) level is set mostly by your DNA and does not change much with diet or exercise. Roughly 20% of the global population carries elevated Lp(a), and those individuals face up to a two- to threefold increase in risk of heart attack and stroke compared to people with low levels.

A prospective analysis from the Copenhagen General Population Study showed that individuals with Lp(a) above the 95th percentile had roughly a 2.6-fold higher risk of heart attack compared to those below the 22nd percentile. Because Lp(a) is largely genetic and does not correlate strongly with other lipid markers, you can have perfect LDL and ApoB numbers while still carrying substantial Lp(a)-driven risk. You only need to measure it once, but you need to measure it at least that once.

Vascular Inflammation

High-sensitivity C-reactive protein (hs-CRP) measures low-grade inflammation throughout your body, including the kind that smolders inside artery walls. The JUPITER trial enrolled over 17,800 apparently healthy people with normal LDL cholesterol but elevated hs-CRP (above 2.0 mg/L) and found that statin therapy reduced major cardiovascular events by 44%, showing that the inflammatory risk identified by hs-CRP is both real and treatable.

A pooled analysis by the Emerging Risk Factors Collaboration, drawing on over 160,000 participants across 54 long-term studies, found that each standard-deviation increase in log-transformed hs-CRP concentration was associated with a roughly 1.37-fold increase in coronary heart disease risk, even after adjusting for traditional risk factors. hs-CRP does not tell you where the inflammation is coming from, but it tells you that it is there, and that is enough to change how aggressively you should act on the rest of your results.

Metabolic and Liver Health

Hemoglobin A1c (HbA1c) reflects your average blood sugar over the past two to three months. Even below the threshold for diabetes, higher HbA1c signals insulin resistance and metabolic dysfunction that independently raise cardiovascular risk. In a study of over 11,000 adults without diabetes from the ARIC cohort, those with HbA1c between 5.5% and 6.0% had a 23% higher risk of cardiovascular disease compared to those with HbA1c below 5.0%, and those with HbA1c between 6.0% and 6.5% had a 78% higher risk.

Alanine aminotransferase (ALT) is a liver enzyme that rises when liver cells are stressed or damaged. In this panel, ALT serves as a window into metabolic liver disease, specifically non-alcoholic fatty liver disease (NAFLD), which affects roughly 25% of adults worldwide. A meta-analysis of 11 prospective studies with over 280,000 participants found that elevated ALT was associated with a 43% increased risk of cardiovascular events. Fatty liver is both a consequence and an accelerator of the same insulin resistance that drives abnormal triglycerides, low HDL, and small dense LDL particles.

How to Read Your Results Together

Individual results matter, but patterns across these tests reveal more than any single number. Here are the most actionable combinations to watch for.

When Results Can Be Misleading

Acute illness, recent surgery, or even a bad cold can spike hs-CRP into ranges that look alarming but have nothing to do with heart risk. If hs-CRP comes back above 10 mg/L, it almost certainly reflects an acute process rather than chronic cardiovascular inflammation. Retest after you have fully recovered.

HbA1c can be falsely high or low depending on red blood cell lifespan. Conditions that shorten red blood cell survival, like hemolytic anemia (where red blood cells break down too quickly) or significant blood loss, will artificially lower HbA1c, while iron deficiency anemia can raise it. ALT can spike from intense exercise, certain medications (statins, acetaminophen), or alcohol consumed in the days before testing. A single elevated ALT reading should always be confirmed with a repeat test.

Triglycerides are the most meal-sensitive marker in this panel. A non-fasting draw can raise triglycerides by 20 to 30 mg/dL or more, which in turn increases the calculated VLDL and may alter the calculated LDL value.

Tracking Over Time

A single snapshot tells you where you stand today. Serial testing, ideally every 6 to 12 months, reveals whether your trajectory is improving or worsening, and whether your interventions are working. This matters because risk factors like ApoB and hs-CRP can change substantially with lifestyle modification or medication, and you want to verify that changes you make are actually moving your numbers.

Lp(a) is the one exception. Because it is genetically determined, it does not change much over time. One measurement is usually sufficient unless you start a therapy specifically targeting Lp(a). For the other nine markers, trends over two to three years are far more informative than any single result. A slowly rising HbA1c from 5.2% to 5.6% over three years, for instance, signals metabolic drift that a single normal result would never reveal.